DS
CLLS

David Shaw’s Cellectis CLLS Stock Holding History

David Shaw’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-47,154
Closed -$74.5K – 4348
2023
Q3 		$74.5K Sell
47,154
-31,675
-40% -$61.9K ﹤0.01% 3880
2023
Q2 		$155K Sell
78,829
-43,701
-36% -$83.8K ﹤0.01% 3786
2023
Q1 		$236K Sell
122,530
-104,582
-46% -$262K ﹤0.01% 3843
2022
Q4 		$477K Sell
227,112
-51,215
-18% -$116K ﹤0.01% 3879
2022
Q3 		$637K Buy
278,327
+6,778
+2% +$20.5K ﹤0.01% 3889
2022
Q2 		$768K Sell
271,549
-28,138
-9% -$99.1K ﹤0.01% 3800
2022
Q1 		$1.36M Buy
299,687
+108,744
+57% +$599K ﹤0.01% 3654
2021
Q4 		$1.55M Buy
190,943
+102,421
+116% +$1.01M ﹤0.01% 3579
2021
Q3 		$1.12M Sell
88,522
-6,747
-7% -$93.5K ﹤0.01% 3516
2021
Q2 		$1.47M Sell
95,269
-3,431
-3% -$57.7K ﹤0.01% 3228
2021
Q1 		$2M Sell
98,700
-19,971
-17% -$494K ﹤0.01% 2588
2020
Q4 		$3.21M Buy
118,671
+1,610
+1% +$36.1K ﹤0.01% 2217
2020
Q3 		$2.17M Sell
117,061
-88,084
-43% -$1.56M ﹤0.01% 2343
2020
Q2 		$3.65M Buy
205,145
+79,929
+64% +$1.22M ﹤0.01% 1911
2020
Q1 		$1.15M Sell
125,216
-67,114
-35% -$1M ﹤0.01% 2635
2019
Q4 		$3.29M Buy
192,330
+55,107
+40% +$736K ﹤0.01% 2071
2019
Q3 		$1.43M Buy
137,223
+105,023
+326% +$1.41M ﹤0.01% 2606
2019
Q2 		$502K Buy
+32,200
New +$575K ﹤0.01% 3085
2018
Q2 		– Sell
-35,705
Closed -$1.13M – 3717
2018
Q1 		$1.13M Buy
+35,705
New +$1.13M ﹤0.01% 2409

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

David Shaw's CLLS Position: Q4 2023 in Review

David Shaw sold out of Cellectis (CLLS) in Q4 2023, closing a stake of 47,154 shares — an estimated $74.5K sold.

David Shaw first reported a position in CLLS in Q1 2018 and held it in 19 quarters. The position peaked at $3.65M in Q2 2020. 34 funds tracked by Wall St. Rank hold CLLS as of Q4 2023.

  • David Shaw reported no remaining Cellectis position as of Q4 2023 after selling out during the quarter.
  • David Shaw sold 47,154 Cellectis shares in Q4 2023, an estimated $74.5K.
  • David Shaw first reported a position in Cellectis in Q1 2018 and held it in 19 quarters.
  • David Shaw's Cellectis position peaked at $3.65M in Q2 2020.
  • 34 funds tracked by Wall St. Rank held Cellectis as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.